[
  {
    "ts": "2025-09-18T20:15:00+00:00",
    "headline": "Top Analyst Reports for AbbVie, ServiceNow & Boeing",
    "summary": "AbbVie, ServiceNow, and Boeing outpace their industries as analysts highlight growth drivers and risks in fresh research reports.",
    "url": "https://finance.yahoo.com/news/top-analyst-reports-abbvie-servicenow-201500374.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3c506b78-2567-34c8-9985-14e0a00af941",
      "content": {
        "id": "3c506b78-2567-34c8-9985-14e0a00af941",
        "contentType": "STORY",
        "title": "Top Analyst Reports for AbbVie, ServiceNow & Boeing",
        "description": "",
        "summary": "AbbVie, ServiceNow, and Boeing outpace their industries as analysts highlight growth drivers and risks in fresh research reports.",
        "pubDate": "2025-09-18T20:15:00Z",
        "displayTime": "2025-09-18T20:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4452e5d22b5b63584264186f98d8d6fe",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CktwzUupuab4LQ.9_WsERw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4452e5d22b5b63584264186f98d8d6fe.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CfPWbUUUjq6KxtkSZ.OMog--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4452e5d22b5b63584264186f98d8d6fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-abbvie-servicenow-201500374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-analyst-reports-abbvie-servicenow-201500374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UBS"
            },
            {
              "symbol": "AMX"
            },
            {
              "symbol": "AMXOF"
            },
            {
              "symbol": "AP"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NOW"
            },
            {
              "symbol": "BA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T15:30:00+00:00",
    "headline": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why",
    "summary": "J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.",
    "url": "https://finance.yahoo.com/news/j-j-expects-innovative-medicines-153000278.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2ca459a6-0f36-3219-86d2-ce844fdc7d99",
      "content": {
        "id": "2ca459a6-0f36-3219-86d2-ce844fdc7d99",
        "contentType": "STORY",
        "title": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why",
        "description": "",
        "summary": "J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.",
        "pubDate": "2025-09-18T15:30:00Z",
        "displayTime": "2025-09-18T15:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ffSS19YaoL36xXdlr0Ip4A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mJhhM1.2_VWzkATXxZYL_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-expects-innovative-medicines-153000278.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-expects-innovative-medicines-153000278.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "TEVA.TA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-18T15:04:13+00:00",
    "headline": "BMO Lifts AbbVie Inc. (ABBV) Price Target to $240 After Rinvoq Litigation Win",
    "summary": "AbbVie Inc. (NYSE:ABBV) is among the high growth mega cap stocks you can buy and hold for the next 3 years. Evan Seigerman, an analyst at BMO Capital, increased the price target on AbbVie Inc. (NYSE:ABBV) to $240 from $215 with an ‘Outperform’ rating. This potential upside of nearly 10% follows the company’s announcement that […]",
    "url": "https://finance.yahoo.com/news/bmo-lifts-abbvie-inc-abbv-150413194.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "bdd819d9-ee76-33ed-a51a-4e54ddc2d029",
      "content": {
        "id": "bdd819d9-ee76-33ed-a51a-4e54ddc2d029",
        "contentType": "STORY",
        "title": "BMO Lifts AbbVie Inc. (ABBV) Price Target to $240 After Rinvoq Litigation Win",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is among the high growth mega cap stocks you can buy and hold for the next 3 years. Evan Seigerman, an analyst at BMO Capital, increased the price target on AbbVie Inc. (NYSE:ABBV) to $240 from $215 with an ‘Outperform’ rating. This potential upside of nearly 10% follows the company’s announcement that […]",
        "pubDate": "2025-09-18T15:04:13Z",
        "displayTime": "2025-09-18T15:04:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "AbbVie (ABBV)'s Dividend Track Record: How It Became a Leader in Consistent Dividends",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aXAa28AvezyRv056g_RUEg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lzVMSqWRbEKelBHS4c050A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-lifts-abbvie-inc-abbv-150413194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-lifts-abbvie-inc-abbv-150413194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]